BROKENSHIRE COLLEGE SOCKSARGEN, INC.

Name: Resurricon, Ronel D. Date: November 23, 2023

Inclusive Date & Shift : November 22, 2023; 7:00 AM – 3:00 PM Clinical Instructor: Nikki Jad Jugar, RN
Area of exposure: SARMED - WARD
Performed: NA
DRUG STUDY

ALGESIA
MECHANISM INDICATION AND ADVERSE NURSING
CLASSIFICATION DOSAGE INSIGHTS
OF ACTION CONTRAINDICATION REACTIONS RESPONSIBILITIES
GENERIC:  Inhibits INDICATIONS: DOSAGE AND ROUTE:  GI Assessment
 CIPRO relaxation of  For the treatment of Adults disturbances;  History: Allergy to  Ciprofloxacin
DNA; inhibits infections caused  Uncomplicated UTIs: 100– headache, ciprofloxacin, antibiotics may
BRAND: DNA gyrase by susceptible 250 mg PO q 12 hr for 3 tremor, norfloxacin or other cause serious
 Ciproxin, in gram-negative days or 500 mg PO daily confusion, quinolones; renal and possibly
Ciloxan, susceptible bacteria, including (ER tablets) for 3 days. convulsions; dysfunction; seizures; permanent
Cetraxal organisms; Escherichia coli, Proquin XR—500 mg PO rashes; joint lactation. tendon damage
promotes Proteus mirabilis, as a single dose. pain;  Physical: Skin color, (such as
PHARMACOLOGI breakage of Klebsiella  Mild to moderate UTIs: phototoxicity. lesions; T; tendonitis,
C CLASS: double- pneumoniae, 250 mg PO q 12 hr for 7– Transient orientation, reflexes, tendon rupture),
 Fluoroquinolone stranded Enterobacter 14 days or 200 mg IV q 12 increases in affect; mucous nerve problems
s DNA cloacae, Proteus hr for 7–14 days. serum membranes, bowel in the arms and
vulgaris, Proteus  Complicated UTIs: 500 mg creatinine. sounds; LFTs, renal legs (peripheral
THERAPEUTIC  Inhibits rettgeri, Morganella PO q 12 hr for 7–14 days Hematologic function tests. neuropathy), and
CLASS: enzyme, morganii, or 400 mg IV q 12 hr or al, hepatic nervous system
 Antibiotics DNA gyrase, Pseudomonas 1,000 mg (ER tablets) PO and renal Interventions problems.
in aeruginosa, daily for 7–14 days. disturbances.  Arrange for culture  CIPRO belongs
susceptible Citrobacter freundii,  Chronic bacterial Vasculitis, and sensitivity tests to a class of
bacteria, Staphylococcus prostatitis: 500 mg PO q pseudomemb before beginning antibiotics called
interfering aureus, 12 hr for 28 days or 400 ranous colitis therapy. fluoroquinolones.
with bacterial Staphylococcus mg IV q 12 hr for 28 days. and  Continue therapy for CIPRO can
cell epidermidis, group  Infectious diarrhea: 500 tachycardia. 2 days after signs cause side
replication. D streptococci. mg q 12 hr PO for 5–7 Phototoxicity. and symptoms of effects that may
 Treatment of days. infection are gone. be serious or
Therapeutic uncomplicated UTIs  Anthrax postexposure:  Potentially  Be aware that even cause
Effect: caused by E. coli, 500 mg PO q 12 hr for 60 Fatal: Proquin XR is not death. If you get
 Bactericidal. K. pneumoniae as a days or 400 mg IV q 12 hr Anaphylactoi interchangeable with any of the
 one-time dose in for 60 days. Respiratory d reaction; other forms. following serious
patients at low risk infections 500–750 mg PO cardiopulmon  Ensure that the side effects, get
of nausea, diarrhea q 12 hr or 400 mg IV q 8– ary arrest. patient swallows ER medical help
(Proquin XR). 12 hr for 7– 14 days. tablets whole; do not right away. Talk
Source:  Otic: Treatment of  Acute sinusitis: 500 mg cut, crush, or chew. with your
acute otitis externa PO q 12 hr or 400 mg IV q PREGNANCY- Ensure that patient is healthcare
 https://  Treatment of 12 hr for 10 days. LACTATION- well hydrated. provider about
reference chronic bacterial  Acute uncomplicated REPRODUCTI  Give antacids at least whether you
.medsca prostatitis pyelonephritis: 1,000 mg ON 2 hr after dosing. should continue
pe.com/  IV: Treatment of ER tablets PO daily for 7–  Ciprofloxacin Monitor clinical to take CIPRO.
drug/ nosocomial 14 days. may cause response; if no
cipro-xr- pneumonia caused  Bone, joint, skin infections: intestinal improvement is seen
ciprofloxa by Haemophilus 500–750 mg PO q 12 hr or flora or a relapse occurs,
cin- influenza, K. 400 mg IV q 8–12 hr for 4– alteration of repeat culture and
342530# pneumoniae 6 wk. breastfeedin sensitivity.
10  Oral: Typhoid fever  Nosocomial g infant;  Encourage patient to
 Oral: STDs caused pneumonia:400 mg IV q 8 advise a complete full course
 Saunders by Neisseria hr for 10–14 days. woman to of therapy.
Nursing gonorrhea  Ophthalmic infections monitor
Drug  Prevention of caused by susceptible breastfed Teaching points.
Handboo anthrax following organisms not responsive infant for  If an antacid is
k 2023, exposure to anthrax to other therapy: 1 or 2 loose or needed, take it at
Book 1, bacilla (prophylactic drops per eye daily or bid bloody stools least 2 hours before
Page No. use in regions or 1/2 inch ribbon of and or after dose.
236 suspected of using ointment into conjunctival candidiasis  Take Proquin XR
germ warfare) sac tid on first 2 days, then (thrush, with the main meal of
 Acute sinusitis apply 1/2 inch ribbon bid diaper rash) the day.
caused by H. for next 5 days.  Do not touch tip of
influenzae,  Acute otitis externa: 4 eye ointment or
Streptococcus drops in infected ear, tid– solution for this may
pneumoniae, or qid. contaminate the
Moraxella product.
catarrhalis Pediatric Patients  Drink plenty of fluids
 Lower respiratory while you are taking
tract infections:  Not recommended; this drug.
Caused by E. Coli, produced lesions of joint  You may experience
Klebsiella, cartilage in immature these side effects:
Enterobacter experimental animals. Nausea, vomiting,
 species, P.  Inhalational anthrax: 15 abdominal pain (eat
mirabilis, P. mg/kg/dose PO q 12 hr for frequent small
aeruginosa, H. 60 days or 10 mg/kg/dose meals); diarrhea or
influenzae, IV q 12 hr for 60 days; do constipation;
Haemophilia not exceed 500 mg/dose drowsiness, blurring
parainfluenza, S. PO or 400 mg/dose IV. of vision, dizziness
pneumoniae (observe caution if
 Unlabeled use: Geriatric Patients or driving or using
Effective in Patients with Impaired dangerous
patients with cystic Renal Function equipment). Report
fibrosis who have  For creatinine clearance of rash, visual changes,
pulmonary 30–50 mL/min, give 250– severe GI problems,
exacerbations 500 mg PO q 12 hr. For weakness, tremors.
creatinine clearance of 5–
CONTRAINDICATION 29 mL/min, give 250–500
 Hypersensitivity. mg PO q 18 hr or 200–400
Not to be used mg IV q 18–24 hr. For
concurrently with patients on hemodialysis,
tizanidine. Avoid give 250–500 mg q 24 hr,
exposure to strong after dialysis.
sunlight or sun
lamps during
treatment.

DRUG
INTERACTION:
 Serious and fatal
reactions have
reported in patients
receiving
concurrent
administration of
ciprofloxacin and
theophylline; if
concomitant use
cannot be avoided,
monitor serum
levels of
theophylline and
adjust dosage as
appropriate.